As of Apr 19
| -0.50 / -0.45%|
The 2 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 116.50, with a high estimate of 120.00 and a low estimate of 113.00. The median estimate represents a +5.43% increase from the last price of 110.50.
The current consensus among 3 polled investment analysts is to Buy stock in Magellan Health Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.